Abstract
Re-treatment of patients with decompensated chronic hepatitis C virus cirrhosis using 24 weeks of sofosbuvir and NS5A inhibitor, with or without ribavirin after failing a 12 week course
- Title
- Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER)
- Creators - without role
- S. Chevaliez - Centre Hospitalier Universitaire Henri-MondorP. Trimoulet - Hôpital PellegrinC. Dorival - Institut Pierre Louis d‘Épidémiologie et de Santé PubliqueS. Larrat - VirologieC. Scholtes - Université catholique de lyonJ.-F. Meritet - Centre d'Investigation Clinique Mère-Enfant Necker Cochin Paris CentreE. Tuaillon - Université de Montpellier, Pathogenesis and Control of Chronic and Emerging Infections - PCCEIL. Bocket - Université Catholique de LilleF. CarratS. Pol - Centre d'Investigation Clinique Mère-Enfant Necker Cochin Paris CentreJ.-M. Pawlotsky - Hôpital Cochin
- Publication Details
- Journal of Hepatology, Vol.66(1)
- Identifiers
- 9944400109311
- Academic Unit
- Pathogenesis and Control of Chronic and Emerging Infections - PCCEI
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-03155282